Literature DB >> 22093271

Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study.

Jan Bucerius1, Raphaël Duivenvoorden, Venkatesh Mani, Colin Moncrieff, James H F Rudd, Claudia Calcagno, Josef Machac, Valentin Fuster, Michael E Farkouh, Zahi A Fayad.   

Abstract

OBJECTIVES: We investigated the prevalence and clinical risk factors of carotid vessel wall inflammation by means of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in a population consisting of coronary artery disease (CAD) patients.
BACKGROUND: The atherosclerotic disease process is characterized by infiltration and retention of oxidized lipids in the artery wall, triggering a disproportionate inflammatory response. Efforts have been made to use noninvasive imaging to quantify this inflammatory response in the vessel wall. Recently, carotid FDG-PET has been shown to reflect the metabolic rate of glucose, a process known to be enhanced in inflamed tissue.
METHODS: Carotid inflammation was quantified in 82 CAD patients (age 62 ± 10 years) as the maximum target-to-background ratio ((wholevessel)TBR(max)). Furthermore, we assessed the maximal standardized uptake value values ((wholevessel)SUV(max)), the single hottest segment (SHS), and the percent active segments (PAS) of the FDG uptake in the artery wall, measured by FDG-PET.
RESULTS: Whole-vessel TBR(max) >1.8 was present in 67%, >2.0 in 39%, >2.2 in 23%, and >2.4 in 12% of the population. Multiple linear regression analysis with backward elimination revealed that body mass index (BMI) ≥30 kg/m2 (p < 0.0001), age >65 years (p = 0.01), smoking (p = 0.02), and hypertension (p = 0.01) were associated with (wholevessel)TBR(max). The number of components of the metabolic syndrome was also associated with (wholevessel)TBR(max) (p = 0.02). In similar analyses, (wholevessel)SUV(max) was associated with BMI ≥30 kg/m2 (p < 0.0001), age >65 years (p = 0.004), male gender (p = 0.02), and hypertension (p = 0.04); SHS with BMI ≥30 kg/m2 (p < 0.0001), age >65 years (p = 0.02), smoking (p = 0.04), and hypertension (p = 0.05); PAS with BMI ≥30 kg/m2 (p = 0.001), smoking (p = 0.03), and hypertension (p = 0.01).
CONCLUSIONS: Carotid inflammation as revealed by FDG-PET is highly prevalent in the CAD population and is associated with obesity, age over 65 years, history of hypertension, smoking, and male gender. Artery wall FDG uptake increased when components of the metabolic syndrome clustered.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22093271      PMCID: PMC4120023          DOI: 10.1016/j.jcmg.2011.07.008

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  37 in total

1.  Novel insights into anti-inflammatory actions of HDL.

Authors:  Diederik F van Wijk; Erik S G Stroes; G M Dallinga-Thie
Journal:  Atherosclerosis       Date:  2010-07-03       Impact factor: 5.162

2.  Statistical methodology for the concurrent assessment of interrater and intrarater reliability: using goniometric measurements as an example.

Authors:  M Eliasziw; S L Young; M G Woodbury; K Fryday-Field
Journal:  Phys Ther       Date:  1994-08

3.  Immunophenotypic characterisation of carotid plaque: increased amount of inflammatory cells as an independent predictor for ischaemic symptoms.

Authors:  H Schumacher; E Kaiser; P A Schnabel; J Sykora; H H Eckstein; J R Allenberg
Journal:  Eur J Vasc Endovasc Surg       Date:  2001-06       Impact factor: 7.069

4.  Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis.

Authors:  Sander I van Leuven; Diederik F van Wijk; Oscar L Volger; Jean-Paul P M de Vries; Chris M van der Loos; Dominique V P de Kleijn; Anton J G Horrevoets; Paul P Tak; Allard C van der Wal; Onno J de Boer; Gerard Pasterkamp; Michael R Hayden; John J P Kastelein; Erik S Stroes
Journal:  Atherosclerosis       Date:  2010-02-06       Impact factor: 5.162

5.  Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography.

Authors:  Hye Jin Yoo; Sungeun Kim; Man Sik Park; Hae Yoon Choi; Sae Jeong Yang; Ji A Seo; Sin Gon Kim; Nan Hee Kim; Sei Hyun Baik; Dong Seop Choi; Kyung Mook Choi
Journal:  J Clin Endocrinol Metab       Date:  2010-12-15       Impact factor: 5.958

Review 6.  Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?

Authors:  James H F Rudd; Jagat Narula; H William Strauss; Renu Virmani; Josef Machac; Mike Klimas; Nobuhiro Tahara; Valentin Fuster; Elizabeth A Warburton; Zahi A Fayad; Ahmed A Tawakol
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

Review 7.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

Review 8.  Obesity and dyslipidemia.

Authors:  Barbara V Howard; Giacomo Ruotolo; David C Robbins
Journal:  Endocrinol Metab Clin North Am       Date:  2003-12       Impact factor: 4.741

9.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.

Authors:  A C van der Wal; A E Becker; C M van der Loos; P K Das
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

10.  Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Authors:  J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

View more
  24 in total

1.  Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study.

Authors:  Frederik F Strobl; Axel Rominger; Sarah Wolpers; Carsten Rist; Fabian Bamberg; Kolja M Thierfelder; Konstantin Nikolaou; Christopher Uebleis; Marcus Hacker; Maximilian F Reiser; Tobias Saam
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-24       Impact factor: 2.357

Review 2.  Molecular imaging in atherosclerosis: FDG PET.

Authors:  David Rosenbaum; Antoine Millon; Zahi A Fayad
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

3.  Quantifying [¹⁸F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction.

Authors:  Björn A Blomberg; Arjun Bashyam; Abhinay Ramachandran; Saeid Gholami; Sina Houshmand; Ali Salavati; Tom Werner; Habib Zaidi; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-05-12       Impact factor: 9.236

4.  Delayed ¹⁸F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study.

Authors:  Björn A Blomberg; Anders Thomassen; Richard A P Takx; Malene G Hildebrandt; Jane A Simonsen; Karen M Buch-Olsen; Axel C P Diederichsen; Hans Mickley; Abass Alavi; Poul F Høilund-Carlsen
Journal:  J Nucl Cardiol       Date:  2014-03-15       Impact factor: 5.952

Review 5.  The advancing clinical impact of molecular imaging in CVD.

Authors:  Eric A Osborn; Farouc A Jaffer
Journal:  JACC Cardiovasc Imaging       Date:  2013-12

6.  Increased Systemic and Plaque Inflammation in ABCA1 Mutation Carriers With Attenuation by Statins.

Authors:  Andrea E Bochem; Fleur M van der Valk; Sonia Tolani; Erik S Stroes; Marit Westerterp; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-19       Impact factor: 8.311

7.  Identification of inflamed atherosclerotic lesions in vivo using PET-CT.

Authors:  Mateja Kaja Jezovnik; Nina Zidar; Luka Lezaic; Borut Gersak; Pavel Poredos
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

8.  Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis.

Authors:  Zahi A Fayad; Jeffrey D Greenberg; Jan Bucerius
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

9.  Carotid Artery FDG Uptake May Serve as a Biomarker for Cardiovascular Risk Stratification in Asymptomatic Adults.

Authors:  Dong Hyun Lee; Su Jin Lee; Duck-Joo Lee; Soo Hyun Kwon; Kyung-Sook Jo; Young-Sil An; Joon-Kee Yoon
Journal:  Nucl Med Mol Imaging       Date:  2014-04-29

Review 10.  Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography.

Authors:  Daniel J Scherer; Peter J Psaltis
Journal:  Cardiovasc Diagn Ther       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.